TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 7 | 0 | 2 | 32 | 17 | 18 | 15 |
| P | %wins | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/21/22 16:09 | 7/20/22 | CTMX | Cytomx Therapeutics, Inc. | Health | Drug | Pharmaceutical Preparations | Hannah Alison L. | CA | O | Chief Me | S | -8 | 1.42 | 0 | -6 | -15 | 32 | D | |||||||||||||||
8/10/20 18:22 | 8/6/20 | NEO | Neogenomics Inc | NV | Health | Biolab | Testing Laboratories | Hannah Alison L. | FL | D | M.d | 73 | 7.27 | 0 | 10 | 13 | 89 | D | |||||||||||||||
9/11/19 20:00 | 9/9/19 | NEO | Neogenomics Inc | NV | Health | Biolab | Testing Laboratories | Hannah Alison L. | FL | D | M.d | 98 | 8.41 | 0 | 12 | 18 | 76 | D | |||||||||||||||
10/3/17 17:19 | 8/9/17 | NEO | Neogenomics Inc | NV | Health | Biolab | Testing Laboratories | Hannah Alison L. | FL | D | M.d | 44 | 6.66 | 0 | 7 | 17 | 45 | D | |||||||||||||||
7/31/17 17:25 | 7/27/17 | NEO | Neogenomics Inc | NV | Health | Biolab | Testing Laboratories | Hannah Alison L. | FL | D | P.d | 184 | 9.19 | 0 | 20 | 106 | 39 | D | |||||||||||||||
5/30/17 21:09 | 5/30/17 | NEO | Neogenomics Inc | NV | Health | Biolab | Testing Laboratories | Hannah Alison L. | FL | D | M.d | 0 | 0.00 | 0 | 7 | 31 | 30 | D | |||||||||||||||
3/4/16 16:31 | 3/3/16 | NEO | Neogenomics Inc | NV | Health | Biolab | Testing Laboratories | Hannah Alison L. | FL | D | P.d | 69 | 6.90 | 2 | 10 | 641 | 12 | D | 84 | 46 | 16 | -13 | 0 | 18 | 17 | 8 | 7 | 0 | 2 | 32 | 17 | 18 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |